EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective

Stephanie Müller, Simone von Bonin, Ralph Schneider, Martin Krüger, Susanne Quick, Percy Schröttner

Frontiers in Cellular and Infection Microbiology · 02.02.2023 · 12

DOI: 10.3389/fcimb.2022.1033639 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 02.02.2023. Verfasst von Stephanie Müller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Shewanella putrefaciens, Gram-Negative Bacterial Infections, Shewanella, Soft Tissue Infections. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shewanella putrefaciens is a gramnegative, facultatively anaerobic, rod shaped bacterium. It belongs to the class of the Gammaproteobacteria and was first described in 1931. S. putrefaciens is part of the marine microflora and especially present in moderate and warm climates. The bacterium is a rare oppurtonistic human pathogen associated mainly with intra-abdominal as well as skin and soft tissue infections. However, it has also been reported in association with more severe diseases such as pneumonia, intracerebral and ocular infections and endocarditis. In these cases the clinical courses are often associated with underlying, predisposing diseases and risk factors. For successful treatment of S. putrefaciens , a combination of appropriate local therapy, e.g. surgical treatment or drainage, and antibiotic therapy should be performed. Since multiple resistances to antibiotics are described, the results of the antimicrobial susceptibility testing must be considered for effective therapy as well. Furthermore, a main challenge in clinical practice is the accurate microbiological identification, and especially the correct differentiation between S. putrefaciens and S. algae . Under certain circumstances, Shewanella -infections can have severe, sometimes even fatal consequences. Therefore, we decided to present the current state of knowledge as well as further aspects with regard to future diagnostics, therapy and research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shewanella putrefaciensGram-Negative Bacterial InfectionsShewanellaSoft Tissue InfectionsHumansAnti-Bacterial Agents

Stichwörter der Autor:innen

ShewanellaShewanella putrefacienshuman infectionrare bacterial pathogenrare human pathogen

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Institute for Medical Microbiology and Virology, University Hospital Carl Gustav Carus, Dresden, Germany.

Zitieren

APA

Müller, S., von Bonin, S., Schneider, R., Krüger, M., Quick, S., & Schröttner, P. (2023). Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.1033639

Vancouver

Müller S, von Bonin S, Schneider R, Krüger M, Quick S, Schröttner P. Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective. Frontiers in Cellular and Infection Microbiology. 2023;12. doi:10.3389/fcimb.2022.1033639

BibTeX
@article{Mller2023,
  author = {Müller, Stephanie and von Bonin, Simone and Schneider, Ralph and Krüger, Martin and Quick, Susanne and Schröttner, Percy},
  title = {Shewanella putrefaciens, a rare human pathogen: A review from a clinical perspective},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {12},
  doi = {10.3389/fcimb.2022.1033639}
}
Kostenlos starten →